Prof. Dr. Juan Ren | Oncology | Excellence in Research

Professor | The First Affiliated Hospital of Xi’an Jiaotong University | China

Dr. Juan Ren, M.D., Ph.D., is a distinguished professor at the Cancer Center of the First Affiliated Hospital of Xi’an Jiaotong University. With a profound dedication to oncology research, she has made significant contributions to understanding cancer biology, particularly in ovarian and endometrial cancers. Her research has led to advancements in tumor markers, angiogenesis, and targeted therapies, establishing her as a leading figure in the field of cancer research.

Profile👤

Scopus

Strengths for the Awards✨

✅ Extensive Research Experience: Dr. Juan Ren has led multiple research projects as a Principal Investigator under prestigious grants, including the National Natural Science Foundation of China and Science & Technology Grants of Shaan’ Xi Province. These projects focus on ovarian cancer, angiogenesis, and targeted cancer therapies, demonstrating a strong track record in cutting-edge oncology research.

✅ Outstanding Publication Record: With over 30 peer-reviewed publications in high-impact journals like Cancer Research, FASEB Journal, and the Journal of Biological Chemistry, Dr. Ren has significantly contributed to the field of cancer biology, epigenetics, and targeted therapy. Publications address crucial aspects of cancer metastasis, angiogenesis, and drug resistance, which align with innovative approaches in cancer treatment.

✅ Recognized Achievements and Awards: Dr. Ren has received multiple prestigious awards, including the First and Second Awards for Excellence in Science and Technology from the Shaan’ Xi Provincial Government and the Cleveland Clinic Foundation’s Excellent Research Award. These accolades highlight a well-respected and impactful career in scientific research.

✅ International Collaboration & Impact: Having worked with institutions like the Cleveland Clinic Foundation, USA, Dr. Ren has demonstrated global research engagement, making their work influential beyond China.

✅ Innovative Contributions to Cancer Treatment: Research focusing on GPR4, VEGF receptors, phospholipase A2 inhibitors, and epigenetic interventions positions Dr. Ren as a pioneer in targeted therapies and precision medicine for cancer treatment.

Education 🎓

Dr. Ren earned her medical degree from Xi’an Medical University, where she was recognized as an outstanding student. She later pursued a Ph.D. at Xi’an Jiaotong University, focusing on cancer research. Her academic excellence was further acknowledged with prestigious awards, highlighting her dedication and contributions to medical science.

Experience 🏥

Dr. Ren has held key positions in academia and research. As a principal investigator, she has led multiple groundbreaking projects funded by the National Natural Science Foundation of China. Her research has explored the molecular mechanisms of cancer progression, metastasis, and treatment resistance. She has collaborated with international institutions, further enriching her expertise and contributions to oncology.

Research Interests On Oncology 🔬

Dr. Ren’s research focuses on:

• The molecular mechanisms of ovarian and endometrial cancers.
• Tumor markers for early cancer detection.
• The role of G-protein-coupled receptors in angiogenesis.
• Epigenetic interventions to enhance cancer treatment.
• The development of novel targeted therapies for gynecological malignancies.

Awards 🏆

Dr. Ren has received numerous prestigious awards, including:

• Second Award of Achievement & Excellence in Science and Technology, Shaan’Xi Province (2013).
• First Award of Achievement & Excellence in Science and Technology, Shaan’Xi Province (2009).
• First Award of Achievement & Excellence in Science and Technology, Anti-Cancer Association of Shaan’Xi Province (2006).
• Excellent Research Award, Cleveland Clinic Foundation, USA (2004).
• Multiple awards for scientific excellence from Xi’an Jiaotong University and the Education Bureau.

Publications 📄

Dr. Ren has authored numerous high-impact research articles. Some key publications include:

• Title: MECOM Locus Classical Transcript Isoforms Affect Tumor Immune Microenvironment and Different Targets in Ovarian Cancer
  Authors: N. Lan, S. Bai, M. Chen, F. Wu, J. Ren
  Publication Year: 2024

• Title: Predictive Role of Elevated Neutrophil-Lymphocyte Ratio for Bone Metastasis in Esophageal Cancer
  Authors: X. Wang, Y. Gao, J. Wang, F. Wu, J. Ren
  Publication Year: 2024

• Title: Construction of lncRNA-m6A Gene-mRNA Regulatory Network to Identify m6A-Related lncRNAs Associated with the Progression of Lung Adenocarcinoma
  Authors: J. Zhang, S. Bai, Y. Yan, X. Wang, J. Ren
  Publication Year: 2023

• Title: Perspective of Radiotherapy for Ovarian Metastasis from Small Cell Lung Cancer
  Authors: Z. Feng, Y. Qu, X. Sun, X. Zhang, Y. Yang
  Publication Year: 2023

• Title: Construction of Prognostic Model of Ovarian Cancer Patients Based on Immune-Related Genes
  Authors: H. Kang, S. Bai, R. Li, J. Zhang, J. Ren
  Publication Year: 2023

• Title: Clinical Association Between Coagulation Indicators and Bone Metastasis in Patients with Gastric Cancer
  Authors: X. Wang, M. Chen, J. Ren, X. Zhang
  Publication Year: 2023

Conclusion 🔍

Dr. Juan Ren’s dedication to oncology research has significantly advanced the understanding of cancer biology. Her contributions in tumor marker identification, molecular targeting, and cancer therapy have shaped modern oncology. Through her research, leadership, and clinical expertise, she continues to inspire and drive innovation in cancer treatment, making a lasting impact on the medical community worldwide.